中國人壽(02628.HK)2022年歸母淨利320.82億元 同比下降36.8%
格隆匯3月29日丨中國人壽(02628.HK)公吿，截至2022年12月31日止年度的業績，公司實現收入合計8043.88億元，同比減少2.5%。歸屬於公司股東的淨利潤320.82億元，同比下降36.8%；每股收益(基本與攤薄)1.14元。
2022年，公司以高質量發展為主題，牢牢守住發展基本盤，綜合實力不斷增強。截至報吿期末，公司總資產、投資資產雙雙突破人民幣5萬億元，其中總資產達人民幣5.25萬億元，投資資產達人民幣5.06萬億元。
公司持續強化資產負債聯動，總投資收益達人民幣1,877.51億元，實現歸屬於公司股東的淨利潤人民幣320.82億元。截至本報吿期末，綜合償付能力充足率和核心償付能力充足率分別為206.78%、143.59%，繼續保持較高水平；公司擁有長險有效保單件數達3.25億份。
報吿期內，公司總保費收入達人民幣6,151.90億元，穩居行業首位。新單保費為人民幣1,847.67億元，同比上升5.1%；首年期交保費為人民幣964.26億元，同比下降2.0%，其中，十年期及以上首年期交保費為人民幣418.21億元，同比上升0.3%，業務結構有所優化。公司一年新業務價值為人民幣360.04億元，內含價值達人民幣12,305.19億元，較2021年底增長2.3%，業務價值繼續引領行業；退保率為0.95%，同比下降0.25個百分點。
回顧2022年，這一年極為重要、極不平凡。外部環境複雜嚴峻，人身險業改革發展任務艱鉅。作為行業"頭雁"，中國人壽堅定不移走中國特色金融發展路，切實發揮經濟運行"減震器"和社會發展"穩定器"功能，沉着應對超預期因素衝擊，迎難而上、砥礪前行，發展態勢穩中向好，市場領先地位穩固，綜合實力持續增強。
公司經營成效得到廣泛認可，連續七年獲中國保險行業協會保險公司法人機構A級經營評價，2022年公司分別位列《福布斯》全球上市公司2000強和《財富》中國500強第71位、第9位，榮獲第十二屆中國證券金紫荊獎"最具投資價值高質量發展上市公司"等殊榮40餘項。董事會建議派發末期股息每10股人民幣4.90元(含税)，將提交2022年年度股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
